NZ583474A - Method for assaying sepsis in humans by determining levels of pancreatic stone protein - Google Patents

Method for assaying sepsis in humans by determining levels of pancreatic stone protein

Info

Publication number
NZ583474A
NZ583474A NZ583474A NZ58347408A NZ583474A NZ 583474 A NZ583474 A NZ 583474A NZ 583474 A NZ583474 A NZ 583474A NZ 58347408 A NZ58347408 A NZ 58347408A NZ 583474 A NZ583474 A NZ 583474A
Authority
NZ
New Zealand
Prior art keywords
psp
reg
sepsis
level
protein
Prior art date
Application number
NZ583474A
Other languages
English (en)
Inventor
Rolf Graf
Daniel Bimmler
Marius Keel
Original Assignee
Univ Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40040164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ583474(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Zuerich filed Critical Univ Zuerich
Publication of NZ583474A publication Critical patent/NZ583474A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/474—Pancreatic thread protein; Reg protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NZ583474A 2007-09-07 2008-09-02 Method for assaying sepsis in humans by determining levels of pancreatic stone protein NZ583474A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07017539 2007-09-07
PCT/EP2008/007158 WO2009030456A1 (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans

Publications (1)

Publication Number Publication Date
NZ583474A true NZ583474A (en) 2011-07-29

Family

ID=40040164

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ583474A NZ583474A (en) 2007-09-07 2008-09-02 Method for assaying sepsis in humans by determining levels of pancreatic stone protein

Country Status (13)

Country Link
US (2) US8435755B2 (enExample)
EP (1) EP2185937B2 (enExample)
JP (1) JP5048838B2 (enExample)
CN (1) CN101796418B (enExample)
AT (1) ATE514950T1 (enExample)
AU (1) AU2008295046B2 (enExample)
CA (1) CA2696319C (enExample)
DK (1) DK2185937T4 (enExample)
ES (1) ES2368877T5 (enExample)
NZ (1) NZ583474A (enExample)
PL (1) PL2185937T5 (enExample)
PT (1) PT2185937E (enExample)
WO (1) WO2009030456A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation
WO2012028594A1 (en) 2010-08-31 2012-03-08 Otto-Von-Guericke-Universität Magdeburg Method for assaying peritonitis in humans
US20130004968A1 (en) * 2010-09-22 2013-01-03 Robert Webber Sepsis blood biomarker system
WO2014009480A1 (en) 2012-07-12 2014-01-16 Universität Zürich Method for assaying sepsis and outcome in humans by detection of psp/reg
WO2014068018A1 (en) * 2012-10-30 2014-05-08 Abbott Gmbh & Co.Kg Methods of prognosis and diagnosis of sepsis
WO2014117165A1 (en) * 2013-01-28 2014-07-31 Vanderbilt University Method for differentiating sepsis and systemic inflammatory response syndrome (sirs)
EP2813852A3 (en) 2013-06-11 2015-03-25 University Of Zurich Method for detecting the development of an infection in humans
CN106367488A (zh) * 2016-08-29 2017-02-01 北京泱深生物信息技术有限公司 Letmd1在脓毒症诊断中的应用
EP3438668A1 (en) 2017-08-04 2019-02-06 B.R.A.H.M.S GmbH Diagnosis and risk stratification of fungal infections
WO2019053118A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh PROADRÉNOMÉDULLINE AS A MARKER OF ABNORMAL PLATELET RATES
EP3502706A1 (en) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
CN108181472B (zh) * 2018-03-05 2020-07-21 吉林大学 昆虫细胞表达psp为校准品的检测psp试剂盒
EP3578989A1 (en) * 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm for prognosis of trauma-related complications in polytrauma patients
FR3087338B1 (fr) 2018-10-22 2020-10-09 Amadeite Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
CA3196464A1 (en) * 2020-11-03 2022-05-12 Nicolas Durand Method for assessing the severity of sars
US20250020663A1 (en) * 2021-11-25 2025-01-16 Abionic Sa Method for the management of antibiotic administration

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0378924B1 (en) 1988-12-21 1996-11-13 The General Hospital Corporation Detection of neurological disease or dysfunction
GB9613629D0 (en) * 1996-06-28 1996-08-28 Univ Leeds Reg gene expression in cancer tissue
DE50105971D1 (de) * 2001-12-04 2005-05-25 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 125
EP1318405B1 (de) 2001-12-04 2004-11-17 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE50103032D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
DE50103030D1 (de) 2001-12-04 2004-09-02 Brahms Ag Verfahren zur Diagnose von Sepsis unter Bestimmung von S100B
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
JP2004194534A (ja) * 2002-12-17 2004-07-15 Sumitomo Pharmaceut Co Ltd 炎症性腸疾患疾患マーカーおよびその利用
EP1581812B1 (en) * 2003-01-06 2008-07-16 Wyeth Compositions and methods for diagnosing and treating colon cancers
WO2004087874A2 (en) * 2003-03-28 2004-10-14 Nuvelo, Inc. Novel nucleic acids and polypeptides
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
DK2577316T3 (en) * 2010-05-31 2017-05-08 Univ Hospital Of Basel Procedure for testing for lower respiratory tract infections or inflammation

Also Published As

Publication number Publication date
CN101796418A (zh) 2010-08-04
CA2696319A1 (en) 2009-03-12
PL2185937T5 (pl) 2014-12-31
AU2008295046B2 (en) 2013-08-01
CA2696319C (en) 2021-02-02
PL2185937T3 (pl) 2012-02-29
PT2185937E (pt) 2011-09-06
US20100222223A1 (en) 2010-09-02
DK2185937T4 (da) 2014-10-20
US9857381B2 (en) 2018-01-02
DK2185937T3 (da) 2011-09-12
ATE514950T1 (de) 2011-07-15
AU2008295046A1 (en) 2009-03-12
EP2185937B1 (en) 2011-06-29
CN101796418B (zh) 2013-05-01
JP2010538282A (ja) 2010-12-09
US20130203612A1 (en) 2013-08-08
ES2368877T3 (es) 2011-11-23
US8435755B2 (en) 2013-05-07
EP2185937B2 (en) 2014-07-16
ES2368877T5 (es) 2014-10-20
JP5048838B2 (ja) 2012-10-17
WO2009030456A1 (en) 2009-03-12
EP2185937A1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
AU2008295046B2 (en) Method for assaying sepsis in humans
EP1709444B1 (en) Method of diagnosing infectious disease by measuring the level of soluble trem-1 in a sample
EP2612152B1 (en) Method to diagnose infectious peritonitis and predict the severity and outcome thereof in humans.
CN102782501B (zh) 在无症状患者中基于il-6检测的全身炎性应答综合征和败血症的早期诊断和预测
US11041864B2 (en) Method for prediction of prognosis of sepsis
US11402390B2 (en) Method for assaying lower respiratory tract infection or inflammation
EP2673646B1 (en) Diagnostic method for urinary tract infection
US20030175713A1 (en) Method for diagnosis of inflammatory diseases using CALGRANULIN C
Palmiere et al. Pancreatic stone protein as a postmortem biochemical marker for the diagnosis of sepsis
US20140186853A1 (en) Method for analyzing mucin 1 using probe capable of binding to 3'-sulfonated core 1 carbohydrate chain, and method for detecting or monitoring breast cancer
US9506923B2 (en) Method of diagnosing surgical site infections
EP3087395B1 (en) Method for detecting a systemic inflammation and test system
CN116298327A (zh) 用于诊断脓毒症的标志物及其用途
EP2813852A2 (en) Method for detecting the development of an infection in humans
WO2019004748A9 (ko) 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법
LU503935B1 (en) An enzyme-linked immunosorbent assay method for detecting amyloid precursor protein fragments in urine quantitatively
Shi et al. Relationships between serum procalcitonin level, severity and different stresses of non-septic critically ill patients
US20070059696A1 (en) Assessment method
KR20250071597A (ko) 미생물 유래 물질에 대한 노출 여부 확인용 바이오마커 및 이의 용도

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2016 BY DENNEMEYER + CO

Effective date: 20150820

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2017 BY THOMSON REUTERS

Effective date: 20160816

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2018 BY DENNEMEYER + CO

Effective date: 20170822

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2019 BY DENNEMEYER + CO

Effective date: 20180821

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2020 BY DENNEMEYER + CO

Effective date: 20190829

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2021 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20200824

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2022 BY DENNEMEYER + CO.

Effective date: 20210823

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2023 BY DENNEMEYER+CO

Effective date: 20220822

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2024 BY DENNEMEYER + CO.

Effective date: 20230822

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2025 BY DENNEMEYER + CO. S.A.R.L.

Effective date: 20240827

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 SEP 2026 BY DENNEMEYER + CO. SARL

Effective date: 20250826